BOURGEON CAPITAL MANAGEMENT LLC - ACHILLION PHARMACEUTICALS IN ownership

ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 143 filers reported holding ACHILLION PHARMACEUTICALS IN in Q4 2019. The put-call ratio across all filers is 0.26 and the average weighting 0.2%.

Quarter-by-quarter ownership
BOURGEON CAPITAL MANAGEMENT LLC ownership history of ACHILLION PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2019$72,000
+71.4%
20,000
-24.5%
0.04%
+44.4%
Q4 2018$42,000
-73.1%
26,500
-37.6%
0.03%
-66.2%
Q3 2018$156,000
+69.6%
42,500
+30.8%
0.08%
+63.3%
Q2 2018$92,000
-24.0%
32,500
-0.0%
0.05%
-25.8%
Q1 2018$121,000
-13.6%
32,502
-33.0%
0.07%
-14.3%
Q4 2017$140,000
+6.1%
48,504
+64.4%
0.08%
-1.3%
Q3 2017$132,000
-16.5%
29,500
-14.5%
0.08%
-21.2%
Q2 2017$158,000
+9.0%
34,5000.0%0.10%
+8.8%
Q1 2017$145,000
+2.1%
34,5000.0%0.09%
+2.2%
Q4 2016$142,000
-18.4%
34,500
+60.5%
0.09%
-19.8%
Q3 2016$174,000
-26.9%
21,500
-29.5%
0.11%
-27.9%
Q2 2016$238,000
+43.4%
30,500
+41.9%
0.15%
+38.7%
Q1 2016$166,000
+33.9%
21,500
+87.0%
0.11%
+38.8%
Q4 2015$124,000
-70.4%
11,500
-81.1%
0.08%
-72.7%
Q3 2015$419,000
-47.9%
60,700
-33.1%
0.29%
-39.8%
Q2 2015$804,000
+48.1%
90,700
+64.6%
0.49%
+46.7%
Q1 2015$543,000
+35.4%
55,100
+68.5%
0.33%
+35.5%
Q4 2014$401,000
+100.5%
32,700
+63.5%
0.24%
+109.4%
Q3 2014$200,000
+102.0%
20,000
-33.3%
0.12%
+88.7%
Q1 2014$99,00030,0000.06%
Other shareholders
ACHILLION PHARMACEUTICALS IN shareholders Q4 2019
NameSharesValueWeighting ↓
MAK CAPITAL ONE LLC 5,191,600$8,255,0004.47%
RTW INVESTMENTS, LP 13,749,383$21,862,0002.04%
ARMISTICE CAPITAL, LLC 4,300,000$6,837,0000.52%
DAFNA Capital Management LLC 630,182$1,002,0000.50%
Rock Springs Capital Management LP 2,325,000$3,697,0000.18%
683 Capital Management, LLC 1,000,000$1,590,0000.10%
Alambic Investment Management, L.P. 133,698$213,0000.09%
South Dakota Investment Council 3,037,004$7,310,0000.08%
Alpine Global Management, LLC 205,172$326,0000.08%
Rhenman & Partners Asset Management AB 402,800$640,0000.07%
View complete list of ACHILLION PHARMACEUTICALS IN shareholders